1. Home
  2. RDY vs CCK Comparison

RDY vs CCK Comparison

Compare RDY & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • CCK
  • Stock Information
  • Founded
  • RDY 1984
  • CCK 1906
  • Country
  • RDY India
  • CCK United States
  • Employees
  • RDY N/A
  • CCK N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • CCK Containers/Packaging
  • Sector
  • RDY Health Care
  • CCK Industrials
  • Exchange
  • RDY Nasdaq
  • CCK Nasdaq
  • Market Cap
  • RDY 13.1B
  • CCK 11.3B
  • IPO Year
  • RDY N/A
  • CCK N/A
  • Fundamental
  • Price
  • RDY $14.21
  • CCK $92.82
  • Analyst Decision
  • RDY Buy
  • CCK Buy
  • Analyst Count
  • RDY 1
  • CCK 13
  • Target Price
  • RDY $17.00
  • CCK $105.83
  • AVG Volume (30 Days)
  • RDY 873.8K
  • CCK 1.1M
  • Earning Date
  • RDY 11-05-2024
  • CCK 10-17-2024
  • Dividend Yield
  • RDY 4.05%
  • CCK 1.08%
  • EPS Growth
  • RDY 4.63
  • CCK N/A
  • EPS
  • RDY 0.76
  • CCK 0.82
  • Revenue
  • RDY $3,579,112,656.00
  • CCK $11,756,000,000.00
  • Revenue This Year
  • RDY $13.39
  • CCK N/A
  • Revenue Next Year
  • RDY $8.35
  • CCK $3.12
  • P/E Ratio
  • RDY $18.81
  • CCK $113.30
  • Revenue Growth
  • RDY 12.37
  • CCK N/A
  • 52 Week Low
  • RDY $12.90
  • CCK $69.61
  • 52 Week High
  • RDY $16.89
  • CCK $98.46
  • Technical
  • Relative Strength Index (RSI)
  • RDY 37.11
  • CCK 51.55
  • Support Level
  • RDY $13.93
  • CCK $88.77
  • Resistance Level
  • RDY $14.40
  • CCK $90.46
  • Average True Range (ATR)
  • RDY 0.27
  • CCK 1.82
  • MACD
  • RDY -0.04
  • CCK -0.16
  • Stochastic Oscillator
  • RDY 18.58
  • CCK 50.44

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About CCK Crown Holdings Inc.

Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

Share on Social Networks: